European Union

“Synthetic biology”: a new name for GMOs?

For the past fifteen years, governments have been discussing “synthetic biology” on an international level. But to date, no definition exists, and the outlines of this field are hard to draw. Are talks of “synthetic biology” simply a change of semantics, or a genuinely new field? For the moment, examples of organisms or molecules obtained by synthetic biology are accumulating : unnatural proteins, GMO plants, GMO bacteria, recreated viruses, modification of living organisms directly in the environment, GMO insects, xenobacteria…

Fungicide and herbicide micropeptides on Europe’s doorstep?

Toulouse-based Micropep Technologies has just had one of its fungicidal micropeptides approved in the United States. The technology, developed and patented by this CNRS spin-off, is aiming for European approval by 2030. However, these micropeptides are raising questions about their potential impact on ecosystems.

“Essentially biological process”, a definition shaken up

During the parliamentary work on the proposal for a European regulation on plant reproductive material, known as the “seeds regulation”, a question arose: should so-called “non-targeted mutagenesis” be considered as an “essentially biological process”? As these processes are excluded from patentability, the question may seem important. But such a decision would not be without consequences for the regulation of GMOs.

2024, a year of vigilance on the GMO file

The European Commission’s proposal to deregulate GMOs made in 2023 will not have come to an end before the European elections, as its promoters had hoped. However, beside the fact that this proposal is not the only file concerning GMOs, the forthcoming period of suspension of European parliamentary work could be used for bilateral discussions.

European and French experts consulted too late on GMO/NGTs ?

While the European Union has been discussing GMO deregulation since July 2023, European and French scientific experts have been and continue to be quite ignored. In France, although the opinion of the Anses was required as early as 2021, its publication took place in March 2024, a month after the vote by MEPs. The latter decided to consult their european experts after the vote, rather than before. However, in order to deliver its opinion in July 2024, the EFSA will make an exception to its procedure: it will not organize a public consultation…

GMO plants, bacteria, viruses and animals: can they all be deregulated?

Seed marketing reform: freeing cultivated biodiversity or patented GMOs?

GMOs/NGTs : a deceptive patent ban

Deregulation of GMOs: 13 organisations call for it to be rejected

French Anses experts : GMO deregulation has « no scientific basis »

The breeders’ gene pool: a semantic trap?

Micro-organisms and industry : a very, very concentrated market